VSee Health Warrant
VSEEW
33 hedge funds and large institutions have $3.47M invested in VSee Health Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 6 reducing their positions, and 0 closing their positions.
6% more funds holding
Funds holding: 31 → 33 (+2)
1% less capital invested
Capital invested by funds: $3.5M → $3.47M (-$38.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$16.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$18.3K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$433 |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$275 |
| 4 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$241 |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$48 |
VSEEW Hedge Fund Activity: Q2 2023 in Review
33 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in VSee Health Warrant (VSEEW) for Q2 2023, worth a combined $3.47M — down 1.1% from $3.5M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VSEEW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 6 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $16.3K. The largest seller was Cowen and Company, cutting an estimated $18.3K.
- 33 institutional investors held VSee Health Warrant (VSEEW) as of Q2 2023, up from 31 in Q1 2023.
- Funds reported $3.47M of VSee Health Warrant stock for Q2 2023, down 1.1% quarter-over-quarter.
- 2 funds opened new VSee Health Warrant positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest VSee Health Warrant buyer in Q2 2023 was Periscope Capital, an estimated $16.3K added.
- The largest VSee Health Warrant seller in Q2 2023 was Cowen and Company, an estimated $18.3K sold.
Based on aggregated 13F filings for Q2 2023.